Analyst Ratings for Pacira Pharmaceuticals (pcrx)
pcrx Rating Summary
pcrx Price Target Summary
- Highest: $57.00 (H.C. Wainwright)
- Lowest: $36.00 (Jefferies)
- Average: $44.70
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.70 (+75.3%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 62%
Avg. $ Target:
$44.70 (+75.3%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/7/2024 | JPMorgan | Hardik Parikh | New Coverage | Overweight (N/A) |
45.00 (N/A) |
29.44 (25.50) |
-13.38% | Details |
| 12/19/2023 | Raymond James | Gary Nachman | New Coverage | Outperform (N/A) |
42.00 (N/A) |
30.85 (25.50) |
-17.34% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
